Bausch & Lomb (BLCO) Return on Capital Employed (2022 - 2026)
Bausch & Lomb (BLCO) reported Return on Capital Employed of 1.9% for Q1 2026, up 127.0% on a YoY basis from 0.84% in Q1 2025, and up 101.41% quarter-over-quarter from 0.94% in Q4 2025.
Bausch & Lomb (BLCO) Return on Capital Employed (2022 - 2026) Analysis & Trends
Bausch & Lomb has reported Return on Capital Employed for 5 years, with the latest figure at 1.9% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 127.0% year-over-year to 1.9%; the trailing twelve-month figure through Mar 2026 stood at 1.9% (up 127.0% YoY), and the FY2025 full-year result was 0.96%, down 43.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 1.9%, up from 0.94% in the prior quarter.
- The five-year high for Return on Capital Employed was 3.06% in Q2 2022, with the low at 0.31% in Q2 2025.
- Historically, Return on Capital Employed has averaged 1.49% across 5 years, with a median of 1.22% in 2023.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 167 bps — and 2026, when it jumped 127 bps.
- Bausch & Lomb's Return on Capital Employed stood at 2.15% in 2022, then plunged by 48 bps to 1.11% in 2023, then gained by 24 bps to 1.38% in 2024, then plunged by 32 bps to 0.94% in 2025, then soared by 101 bps to 1.9% in 2026.
- The last three Return on Capital Employed figures came in at 1.9% (Q1 2026), 0.94% (Q4 2025), and 0.74% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 1.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90% |
| Dec 31, 2025 | 0.94% |
| Sep 30, 2025 | 0.74% |
| Jun 30, 2025 | 0.31% |
| Mar 31, 2025 | 0.62% |
| Dec 31, 2024 | 1.38% |
| Sep 30, 2024 | 1.07% |
| Jun 30, 2024 | 1.04% |
| Mar 31, 2024 | 1.17% |
| Dec 31, 2023 | 1.11% |
| Sep 30, 2023 | 1.22% |
| Jun 30, 2023 | 1.39% |
| Mar 31, 2023 | 1.52% |
| Dec 31, 2022 | 2.15% |
| Sep 30, 2022 | 2.57% |
| Jun 30, 2022 | 3.06% |
| Mar 31, 2022 | 3.05% |